373 related articles for article (PubMed ID: 31987840)
1. Molecular changes in hepatic metabolism in ZDSD rats-A new polygenic rodent model of obesity, metabolic syndrome, and diabetes.
Han L; Bittner S; Dong D; Cortez Y; Bittner A; Chan J; Umar M; Shen WJ; Peterson RG; Kraemer FB; Azhar S
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165688. PubMed ID: 31987840
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the ZDSD Rat: A Translational Model for the Study of Metabolic Syndrome and Type 2 Diabetes.
Peterson RG; Jackson CV; Zimmerman K; de Winter W; Huebert N; Hansen MK
J Diabetes Res; 2015; 2015():487816. PubMed ID: 25961053
[TBL] [Abstract][Full Text] [Related]
3. Zucker Diabetic-Sprague Dawley (ZDSD) rat: Type 2 diabetes translational research model.
Wang AN; Carlos J; Fraser GM; McGuire JJ
Exp Physiol; 2022 Apr; 107(4):265-282. PubMed ID: 35178802
[TBL] [Abstract][Full Text] [Related]
4. Wound Healing Delay in the ZDSD Rat.
Suckow MA; Gobbett TA; Peterson RG
In Vivo; 2017 Jan; 31(1):55-60. PubMed ID: 28064221
[TBL] [Abstract][Full Text] [Related]
5. Characterization of diabetic neuropathy in the Zucker diabetic Sprague-Dawley rat: a new animal model for type 2 diabetes.
Davidson EP; Coppey LJ; Holmes A; Lupachyk S; Dake BL; Oltman CL; Peterson RG; Yorek MA
J Diabetes Res; 2014; 2014():714273. PubMed ID: 25371906
[TBL] [Abstract][Full Text] [Related]
6. Skeletal changes associated with the onset of type 2 diabetes in the ZDF and ZDSD rodent models.
Reinwald S; Peterson RG; Allen MR; Burr DB
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E765-74. PubMed ID: 19158319
[TBL] [Abstract][Full Text] [Related]
7. Induction of diabetes by Tacrolimus in a phenotypic model of obesity and metabolic syndrome.
Teixidó-Trujillo S; Porrini E; Menéndez-Quintanal LM; Torres-Ramírez A; Fumero C; Rodríguez-Rodríguez AE
Front Endocrinol (Lausanne); 2024; 15():1388361. PubMed ID: 38745946
[TBL] [Abstract][Full Text] [Related]
8. Alteration of Liver Peroxisomal and Mitochondrial Functionality in the NZO Mouse Model of Metabolic Syndrome.
Knebel B; Göddeke S; Hartwig S; Hörbelt T; Fahlbusch P; Al-Hasani H; Jacob S; Koellmer C; Nitzgen U; Schiller M; Lehr S; Kotzka J
Proteomics Clin Appl; 2018 Jan; 12(1):. PubMed ID: 29068532
[TBL] [Abstract][Full Text] [Related]
9. Changes in the Fracture Resistance of Bone with the Progression of Type 2 Diabetes in the ZDSD Rat.
Creecy A; Uppuganti S; Merkel AR; O'Neal D; Makowski AJ; Granke M; Voziyan P; Nyman JS
Calcif Tissue Int; 2016 Sep; 99(3):289-301. PubMed ID: 27209312
[TBL] [Abstract][Full Text] [Related]
10. Endothelium dysfunction in hind limb arteries of male Zucker Diabetic-Sprague Dawley rats.
Wang AN; Carlos J; Singh KK; Fraser GM; McGuire JJ
Biochem Pharmacol; 2022 Dec; 206():115319. PubMed ID: 36279920
[TBL] [Abstract][Full Text] [Related]
11. Modeling the Disease Progression from Healthy to Overt Diabetes in ZDSD Rats.
Choy S; de Winter W; Karlsson MO; Kjellsson MC
AAPS J; 2016 Sep; 18(5):1203-1212. PubMed ID: 27245226
[TBL] [Abstract][Full Text] [Related]
12. Diet modification and its influence on metabolic and related pathological alterations in the SHR/NDmcr-cp rat, an animal model of the metabolic syndrome.
Kawai K; Sakairi T; Harada S; Shinozuka J; Ide M; Sato H; Tanaka M; Toriumi W; Kume E
Exp Toxicol Pathol; 2012 May; 64(4):333-8. PubMed ID: 20965707
[TBL] [Abstract][Full Text] [Related]
13. Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia.
Kohen-Avramoglu R; Theriault A; Adeli K
Clin Biochem; 2003 Sep; 36(6):413-20. PubMed ID: 12951167
[TBL] [Abstract][Full Text] [Related]
14. Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging.
Gong Z; Tas E; Yakar S; Muzumdar R
Mol Cell Endocrinol; 2017 Nov; 455():115-130. PubMed ID: 28017785
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance: a genetic approach. Overview.
Martínez Larrad MT; González Sánchez JL; Serrano Ríos M
Nestle Nutr Workshop Ser Clin Perform Programme; 2002; 6():79-93; discussion 93-5. PubMed ID: 16969968
[No Abstract] [Full Text] [Related]
16. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of microRNA-125a contributes to obesity-associated insulin resistance and dysregulates lipid metabolism in mice.
Liu R; Wang M; Li E; Yang Y; Li J; Chen S; Shen WJ; Azhar S; Guo Z; Hu Z
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May; 1865(5):158640. PubMed ID: 31988048
[TBL] [Abstract][Full Text] [Related]
18. Synthetic protease inhibitor camostat prevents and reverses dyslipidemia, insulin secretory defects, and histological abnormalities of the pancreas in genetically obese and diabetic rats.
Jia D; Taguchi M; Otsuki M
Metabolism; 2005 May; 54(5):619-27. PubMed ID: 15877292
[TBL] [Abstract][Full Text] [Related]
19. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic function of spontaneously diabetic torii rats in pre-diabetic stage.
Matsui K; Oda T; Nishizawa E; Sano R; Yamamoto H; Fukuda S; Sasase T; Miyajima K; Ueda N; Ishii Y; Ohta T; Matsushita M
Exp Anim; 2009 Jul; 58(4):363-74. PubMed ID: 19654434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
